Condition: Acute Mesenteric Ischemia · Sponsor: University of Tartu
Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.
This description comes directly from the study's public registry record.
Annika Reintam Blaser, PhD · +3725142281 · annika.reintam.blaser@ut.ee
Always discuss trial participation with your own doctor first.
| Tartu University Hospital | Tartu, Estonia | Recruiting |
| Lucerne Cantonal Hospital | Lucerne, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06212921